Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446
11.00
+1.29%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
11.00 on 9 Oct 2026
18 10 2 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $2.00 14 Oct 2025 $1.88 15 Oct 2025 $1.94 16 Oct 2025 $1.95 17 Oct 2025 $1.93 20 Oct 2025 $2.32 21 Oct 2025 $2.26 22 Oct 2025 $2.06 23 Oct 2025 $1.99 24 Oct 2025 $1.99 27 Oct 2025 $2.10 28 Oct 2025 $2.08 29 Oct 2025 $2.08 30 Oct 2025 $1.99 31 Oct 2025 $2.05 3 Nov 2025 $2.00 4 Nov 2025 $1.88 5 Nov 2025 $1.92 6 Nov 2025 $1.95 7 Nov 2025 $1.83 10 Nov 2025 $1.80 11 Nov 2025 $1.90 12 Nov 2025 $1.92 13 Nov 2025 $1.87 14 Nov 2025 $1.90 17 Nov 2025 $1.88 18 Nov 2025 $1.91 19 Nov 2025 $1.84 20 Nov 2025 $1.73 21 Nov 2025 $1.70 24 Nov 2025 $1.76 25 Nov 2025 $1.80 26 Nov 2025 $1.84 28 Nov 2025 $1.89 1 Dec 2025 $1.79 2 Dec 2025 $1.64 3 Dec 2025 $1.74 4 Dec 2025 $1.73 5 Dec 2025 $1.72 8 Dec 2025 $1.81 9 Dec 2025 $1.90 10 Dec 2025 $2.08 11 Dec 2025 $2.30 12 Dec 2025 $3.00 15 Dec 2025 $3.81 16 Dec 2025 $4.62 17 Dec 2025 $4.25 18 Dec 2025 $4.38 19 Dec 2025 $4.28 22 Dec 2025 $4.90 23 Dec 2025 $4.60 24 Dec 2025 $4.85 26 Dec 2025 $4.93 29 Dec 2025 $4.44 30 Dec 2025 $4.03 31 Dec 2025 $4.00 2 Jan 2026 $3.75 5 Jan 2026 $3.54 6 Jan 2026 $3.81 7 Jan 2026 $4.20 8 Jan 2026 $4.58 9 Jan 2026 $5.03 12 Jan 2026 $4.70 13 Jan 2026 $4.13 14 Jan 2026 $3.96 15 Jan 2026 $3.77 16 Jan 2026 $4.22 20 Jan 2026 $4.32 21 Jan 2026 $4.29 22 Jan 2026 $4.91 23 Jan 2026 $5.02 26 Jan 2026 $4.77 27 Jan 2026 $5.12 28 Jan 2026 $5.16 29 Jan 2026 $4.78 30 Jan 2026 $4.47 2 Feb 2026 $4.73 3 Feb 2026 $5.15 4 Feb 2026 $5.05 5 Feb 2026 $4.65 6 Feb 2026 $5.44 9 Feb 2026 $5.77 10 Feb 2026 $5.50 11 Feb 2026 $5.56 12 Feb 2026 $5.27 13 Feb 2026 $5.67 17 Feb 2026 $5.61 18 Feb 2026 $5.50 19 Feb 2026 $5.64 20 Feb 2026 $5.63 23 Feb 2026 $5.83 24 Feb 2026 $6.36 25 Feb 2026 $7.09 26 Feb 2026 $7.38 27 Feb 2026 $7.15 2 Mar 2026 $7.07 3 Mar 2026 $7.09 4 Mar 2026 $7.28 5 Mar 2026 $7.39 6 Mar 2026 $7.18 9 Mar 2026 $7.25 10 Mar 2026 $7.33 11 Mar 2026 $7.33 12 Mar 2026 $7.26 13 Mar 2026 $7.03 16 Mar 2026 $7.13 17 Mar 2026 $7.12 18 Mar 2026 $7.12 19 Mar 2026 $6.98 20 Mar 2026 $6.11 23 Mar 2026 $6.54 24 Mar 2026 $6.68 25 Mar 2026 $6.98 26 Mar 2026 $7.11 27 Mar 2026 $7.02 30 Mar 2026 $6.54 31 Mar 2026 $6.85 1 Apr 2026 $6.95 2 Apr 2026 $6.56 6 Apr 2026 $6.74 7 Apr 2026 $6.87 8 Apr 2026 $7.10 9 Apr 2026 $8.05 10 Apr 2026 $8.41 13 Apr 2026 $8.63 14 Apr 2026 $8.85 15 Apr 2026 $8.65 16 Apr 2026 $8.82 17 Apr 2026 $9.16 20 Apr 2026 $8.97 21 Apr 2026 $9.37 22 Apr 2026 $9.30 23 Apr 2026 $9.02 24 Apr 2026 $9.14 27 Apr 2026 $9.50 28 Apr 2026 $9.26 29 Apr 2026 $8.78 30 Apr 2026 $8.88 1 May 2026 $8.91 4 May 2026 $9.69 5 May 2026 $11.45 6 May 2026 $12.22 7 May 2026 $11.91 8 May 2026 $11.37 11 May 2026 $11.12 12 May 2026 $11.17 13 May 2026 $11.41 14 May 2026 $11.33 15 May 2026 $10.80 18 May 2026 $9.88 19 May 2026 $9.65 20 May 2026 $10.52 21 May 2026 $10.91 22 May 2026 $11.00 26 May 2026 $11.39 27 May 2026 $11.96 28 May 2026 $11.34 29 May 2026 $10.96 1 Jun 2026 $11.80 2 Jun 2026 $11.20 3 Jun 2026 $10.44 4 Jun 2026 $10.91 5 Jun 2026 $10.55 8 Jun 2026 $10.77 9 Jun 2026 $11.14 10 Jun 2026 $10.80 11 Jun 2026 $10.91 12 Jun 2026 $11.44 15 Jun 2026 $11.49 16 Jun 2026 $10.71 17 Jun 2026 $11.34 18 Jun 2026 $11.45 22 Jun 2026 $12.18 23 Jun 2026 $12.30 24 Jun 2026 $12.75 25 Jun 2026 $12.66 26 Jun 2026 $13.08 29 Jun 2026 $13.36 30 Jun 2026 $13.04 1 Jul 2026 $13.29 2 Jul 2026 $12.90 6 Jul 2026 $13.27 7 Jul 2026 $13.42 8 Jul 2026 $13.57 9 Jul 2026 $13.82 10 Jul 2026 $14.00 13 Jul 2026 $13.21 14 Jul 2026 $13.24 15 Jul 2026 $13.87 16 Jul 2026 $12.58 17 Jul 2026 $12.70 20 Jul 2026 $12.22 21 Jul 2026 $13.10 22 Jul 2026 $12.58 23 Jul 2026 $12.76 24 Jul 2026 $12.84 27 Jul 2026 $12.79 28 Jul 2026 $12.29 29 Jul 2026 $12.11 30 Jul 2026 $12.08 31 Jul 2026 $11.90 3 Aug 2026 $11.81 4 Aug 2026 $12.56 5 Aug 2026 $12.47 6 Aug 2026 $14.00 7 Aug 2026 $14.00 10 Aug 2026 $13.54 11 Aug 2026 $13.85 12 Aug 2026 $14.39 13 Aug 2026 $14.73 14 Aug 2026 $16.33 17 Aug 2026 $17.44 18 Aug 2026 $17.39 19 Aug 2026 $17.34 20 Aug 2026 $17.02 21 Aug 2026 $17.28 24 Aug 2026 $16.40 25 Aug 2026 $17.84 26 Aug 2026 $16.08 27 Aug 2026 $15.06 28 Aug 2026 $14.57 31 Aug 2026 $13.73 1 Sep 2026 $14.82 2 Sep 2026 $15.05 3 Sep 2026 $14.59 4 Sep 2026 $15.52 8 Sep 2026 $15.90 9 Sep 2026 $15.05 10 Sep 2026 $14.95 11 Sep 2026 $14.25 14 Sep 2026 $14.56 15 Sep 2026 $13.91 16 Sep 2026 $14.11 17 Sep 2026 $14.06 18 Sep 2026 $14.05 21 Sep 2026 $13.64 22 Sep 2026 $14.21 23 Sep 2026 $12.52 24 Sep 2026 $11.89 25 Sep 2026 $11.66 28 Sep 2026 $11.74 29 Sep 2026 $11.50 30 Sep 2026 $11.47 1 Oct 2026 $11.07 2 Oct 2026 $10.94 5 Oct 2026 $11.05 6 Oct 2026 $10.68 7 Oct 2026 $10.71 8 Oct 2026 $10.86 9 Oct 2026 $11.00 RA CAPITAL MANAGEMENT, L.P. Director Bought $464.56K 11 Dec 2025 · at $2.18 · 6.9% of stake RA CAPITAL MANAGEMENT, L.P. Director Bought $290.18K 12 Dec 2025 · at $2.86 · 3.1% of stake RA CAPITAL MANAGEMENT, L.P. Director Bought $24.89K 5 Jan 2026 · at $3.50 · 0.2% of stake Thomas Stephen Basil Director Sold on a plan $470.99K 12 Feb 2026 · at $5.23 · 29.5% of stake Thomas Stephen Basil Director Sold on a plan $58.14K 13 Feb 2026 · at $5.81 · 4.7% of stake Thomas Stephen Basil Director Sold on a plan $235.96K 25 Feb 2026 · at $7.00 · 16.5% of stake Thomas Stephen Basil Director Sold on a plan $114.29K 26 Feb 2026 · at $7.01 · 9.5% of stake Brennan Aoife President and CEO Sold on a plan $406.98K 29 Jun 2026 · at $13.17 · 26.0% of stake Thomas Stephen Basil Director Sold on a plan $1.37M 15 Sep 2026 · at $13.67 · 17.6% of stake
3 buys0 sales at will6 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$59.85M
Free cash flow
$54.54M
Return on equity
-37.3%
Return on capital
-33.4%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -21M FY20 Fiscal year 2020 Revenue $0.00 Net income $20.67M Margin n/a 0K -47M FY21 Fiscal year 2021 Revenue $0.00 Net income $47.48M Margin n/a 0K -45M FY22 Fiscal year 2022 Revenue $0.00 Net income $45.24M Margin n/a 0K -35M FY23 Fiscal year 2023 Revenue $0.00 Net income $35.12M Margin n/a 0K -74M FY24 Fiscal year 2024 Revenue $0.00 Net income $73.90M Margin n/a 0K -60M FY25 Fiscal year 2025 Revenue $0.00 Net income $59.85M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
15 Sep 2026 Thomas Stephen Basil
Director
Sold on a plan $1.37M 17.6%
29 Jun 2026 Brennan Aoife
President and CEO
Sold on a plan $406.98K 26.0%
26 Feb 2026 Thomas Stephen Basil
Director
Sold on a plan $114.29K 9.5%
25 Feb 2026 Thomas Stephen Basil
Director
Sold on a plan $235.96K 16.5%
13 Feb 2026 Thomas Stephen Basil
Director
Sold on a plan $58.14K 4.7%
12 Feb 2026 Thomas Stephen Basil
Director
Sold on a plan $470.99K 29.5%